Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will specify on the NYSE American stock substitution this morning throug...

ALX's waning CD47 action cost delivers sell spiraling down

.ALX Oncology's period 2 stomach cancer reaction rate has deteriorated. After finding its CD47 block...

Ionis axes eye disease coming from intendeds of Roche-partnered possibility after information dissatisfy

.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has actually disappointed assumptions...

Biogen's chief executive officer mentioned no risky handle 2023. He prepares to become vibrant

.While Biogen's pharma peers are searching for late-stage resources along with little threat, chief ...

Instil refills pipe in $2B biobucks take care of ImmunOnco

.Instil Biography has actually been actually a biotech trying to find a pipeline after it junked its...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored legal rights to a very early Alzheimer's ailment plan to Denali Therap...

Takeda touches new mind people oncology business-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings a...

Vertex, beaten through AATD once again, drops 2 properties on discard pile

.Vertex's try to handle a rare hereditary condition has struck an additional obstacle. The biotech t...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of personnel

.Vir Biotechnology's second-quarter earnings report wasn't except big headlines. The firm accepted a...

Galapagos stops CAR-T tissue therapy trial over Parkinsonism instance

.Galapagos has actually stopped application in a test of a BCMA-directed CAR-T cell treatment, pushi...